Skip to main content
Log in

Severe hepatorenal failure in a child receiving carbamazepine and erythromycin

  • Letters to the Editors
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

CBZ:

carbamazepine

EM:

erythromycin

References

  1. Askmark H, Wiholm B (1990) Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system. Acta Neurol Scand 81:131–140

    PubMed  Google Scholar 

  2. Baciewicz AM (1986) Carbamazepine drug interactions. Ther Drug Monit 8:305–317

    PubMed  Google Scholar 

  3. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E (1981) Carbamazepine-induced acute tubulointerstistial nephritis. J Pediatr 98:830–832

    PubMed  Google Scholar 

  4. Hordon LD, Turney JH (1987) Membranous glomerulopathy associated with carbamazepine. BMJ 294–375

  5. Horowitz S, Patwardhan R, Marcus E (1986) Carbamazepine hepatotoxicity. Epilepsia 27:592

    Google Scholar 

  6. Murphy JV, Roberts CC, Francisco CB (1989) Fulminant hepatorenal failure in two patients receiving carbamazepine. Ann Neurol 26:458

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Viani, F., Claris-Appiani, A., Rossi, L.N. et al. Severe hepatorenal failure in a child receiving carbamazepine and erythromycin. Eur J Pediatr 151, 715 (1992). https://doi.org/10.1007/BF01957582

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957582

Keywords

Navigation